Deutsche Bank’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Deutsche Bank’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,314	Closed	-$12K	–	5238
2016 Q3	$12K	Buy	3,314 +2,714	+452%	+$12.4K	﹤0.01%	4643
2016 Q2	$3K	Sell	600 -100	-14%	-$570	﹤0.01%	5071
2016 Q1	$3K	Buy	+700	New	+$3.07K	﹤0.01%	5029
2015 Q4	–	Sell	-1,200	Closed	-$4K	–	5519
2015 Q3	$4K	Sell	1,200 -24,200	-95%	-$168K	﹤0.01%	5072
2015 Q2	$217K	Sell	25,400 -13,400	-35%	-$134K	﹤0.01%	3852
2015 Q1	$350K	Buy	+38,800	New	+$487K	﹤0.01%	3493

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Deutsche Bank's CPHR Position: Q4 2016 in Review

Deutsche Bank sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 3,314 shares — an estimated $12K sold.

Deutsche Bank first reported a position in CPHR in Q1 2015 and held it in 6 quarters. The position peaked at $350K in Q1 2015. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Deutsche Bank reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Deutsche Bank sold 3,314 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $12K.
Deutsche Bank first reported a position in Cipher Pharmaceuticals Inc. in Q1 2015 and held it in 6 quarters.
Deutsche Bank's Cipher Pharmaceuticals Inc. position peaked at $350K in Q1 2015.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.